Martella Noemi, Pensabene Daniele, Varone Michela, Colardo Mayra, Petraroia Michele, Sergio William, La Rosa Piergiorgio, Moreno Sandra, Segatto Marco
Department of Biosciences and Territory, University of Molise, Contrada Fonte Lappone, 86090 Pesche, Italy.
Department of Science, University Roma Tre, Viale Marconi 446, 00146 Rome, Italy.
Biomedicines. 2023 Mar 1;11(3):750. doi: 10.3390/biomedicines11030750.
BET proteins function as histone code readers of acetylated lysins that determine the positive regulation in transcription of genes involved in cell cycle progression, differentiation, inflammation, and many other pathways. In recent years, thanks to the development of BET inhibitors, interest in this protein family has risen for its relevance in brain development and function. For example, experimental evidence has shown that BET modulation affects neuronal activity and the expression of genes involved in learning and memory. In addition, BET inhibition strongly suppresses molecular pathways related to neuroinflammation. These observations suggest that BET modulation may play a critical role in the onset and during the development of diverse neurodegenerative and neuropsychiatric disorders, such as Alzheimer's disease, fragile X syndrome, and Rett syndrome. In this review article, we summarize the most recent evidence regarding the involvement of BET proteins in brain physiology and pathology, as well as their pharmacological potential as targets for therapeutic purposes.
BET蛋白作为乙酰化赖氨酸的组蛋白编码阅读器,决定了参与细胞周期进程、分化、炎症和许多其他途径的基因转录的正向调控。近年来,由于BET抑制剂的发展,人们对这个蛋白质家族因其在大脑发育和功能中的相关性而产生了兴趣。例如,实验证据表明,BET调节会影响神经元活动以及参与学习和记忆的基因表达。此外,BET抑制强烈抑制与神经炎症相关的分子途径。这些观察结果表明,BET调节可能在多种神经退行性和神经精神疾病(如阿尔茨海默病、脆性X综合征和雷特综合征)的发病和发展过程中起关键作用。在这篇综述文章中,我们总结了关于BET蛋白参与大脑生理和病理的最新证据,以及它们作为治疗靶点的药理学潜力。